ANL
Price
$1.64
Change
-$0.04 (-2.38%)
Updated
Aug 25 closing price
Capitalization
60.52M
JAZZ
Price
$124.59
Change
+$1.48 (+1.20%)
Updated
Aug 25 closing price
Capitalization
7.56B
71 days until earnings call
Interact to see
Advertisement

ANL vs JAZZ

Header iconANL vs JAZZ Comparison
Open Charts ANL vs JAZZBanner chart's image
Adlai Nortye
Price$1.64
Change-$0.04 (-2.38%)
Volume$7.53K
Capitalization60.52M
Jazz Pharmaceuticals
Price$124.59
Change+$1.48 (+1.20%)
Volume$1.01M
Capitalization7.56B
ANL vs JAZZ Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. JAZZ commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a StrongBuy and JAZZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ANL: $1.64 vs. JAZZ: $124.59)
Brand notoriety: ANL and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 101% vs. JAZZ: 122%
Market capitalization -- ANL: $60.52M vs. JAZZ: $7.56B
ANL [@Biotechnology] is valued at $60.52M. JAZZ’s [@Biotechnology] market capitalization is $7.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 6 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 4 bearish.
  • JAZZ’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а -8.84% price change this week, while JAZZ (@Biotechnology) price change was +5.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +23.43%, and the average quarterly price growth was +29.28%.

Reported Earning Dates

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.56B) has a higher market cap than ANL($60.5M). JAZZ YTD gains are higher at: 1.169 vs. ANL (-38.924). JAZZ has higher annual earnings (EBITDA): 372M vs. ANL (-49.89M). JAZZ has more cash in the bank: 1.67B vs. ANL (98M). ANL has less debt than JAZZ: ANL (39.5M) vs JAZZ (5.43B). JAZZ has higher revenues than ANL: JAZZ (4.09B) vs ANL (5M).
ANLJAZZANL / JAZZ
Capitalization60.5M7.56B1%
EBITDA-49.89M372M-13%
Gain YTD-38.9241.169-3,329%
P/E RatioN/A15.38-
Revenue5M4.09B0%
Total Cash98M1.67B6%
Total Debt39.5M5.43B1%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLJAZZ
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 15 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
60%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRHI1.000.01
+1.01%
Veri Medtech Holdings Inc.
RDEIF20.04N/A
N/A
Redeia Corporacion SA
AMTPQ0.01N/A
N/A
Ameritrans Capital Corp.
FNRN12.00N/A
N/A
First Northern Community Bancorp
KSRYY7.54N/A
N/A
Kose Corp.

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.11%
FGHQF - ANL
25%
Poorly correlated
N/A
NVCT - ANL
21%
Poorly correlated
-5.53%
JAZZ - ANL
21%
Poorly correlated
+1.20%
VCEL - ANL
21%
Poorly correlated
-3.35%
MDXG - ANL
21%
Poorly correlated
-3.15%
More